guidelin
provid
recommend
support
hospit
clinician
manag
critic
ill
adult
intens
care
unit
icu
target
user
guidelin
frontlin
clinician
alli
health
profession
policymak
involv
care
patient
icu
guidelin
appli
high
lowmiddl
incom
set
surviv
sepsi
campaign
ssc
subcommitte
select
panel
member
way
obtain
balanc
topic
expertis
geograph
locat
far
possibl
gender
ssc
panel
assembl
work
within
tight
timelin
order
issu
recommend
time
manner
panel
includ
expert
guidelin
develop
infect
control
infecti
diseas
microbiolog
critic
care
emerg
medicin
nurs
public
health
panel
divid
four
group
infect
control
test
hemodynam
support
ventilatori
support
therapi
guidelin
intens
care
develop
evalu
guid
group
provid
methodolog
support
throughout
guidelin
develop
process
panel
member
complet
conflict
interest
coi
form
prior
join
guidelin
panel
use
gradepro
guidelin
develop
tool
gdt
onlin
softwar
http
gdtguidelinedevelopmentorg
administ
coi
disclosur
form
particip
panel
member
direct
financi
industryrel
coi
permit
consid
disqualifi
develop
guidelin
includ
industri
input
fund
financi
nonfinanci
contribut
member
guidelin
panel
receiv
honoraria
remuner
role
guidelin
develop
process
question
help
profession
medic
librarian
electron
search
major
databas
ie
cochran
central
medlin
identifi
relev
systemat
review
random
control
trial
rct
observ
studi
case
seri
electron
search
perform
look
studi
publish
english
incept
march
inform
recommend
hemodynam
ventilatori
support
use
recent
publish
systemat
review
ask
expert
identifi
new
relev
studi
select
pico
question
pair
review
screen
titl
abstract
retriev
bibliograph
databas
pico
question
potenti
elig
studi
assess
elig
accord
prespecifi
criteria
content
expert
ask
indic
addit
studi
identifi
search
subsequ
pair
review
independ
abstract
relev
data
correspond
pico
question
item
relev
risk
bia
obtain
intentiontotreat
data
whenev
avail
otherwis
use
complet
case
data
ie
ignor
miss
data
use
grade
recommend
assess
develop
evalu
grade
approach
assess
qualiti
evid
ie
confid
estim
effect
support
recommend
qualiti
evid
rate
high
moder
low
low
use
gdt
onlin
softwar
http
gdtguidelinedevelopmentorg
gener
evid
profil
evid
summari
given
recent
emerg
anticip
would
scarciti
direct
evid
therefor
use
predefin
algorithm
decid
whether
indirect
evid
could
inform
specif
question
fig
supplement
digit
content
http
ssc
panel
decid
popul
extrapol
evid
base
context
recommend
likelihood
presenc
effect
modifi
fig
supplement
digit
content
http
accordingli
use
sourc
indirect
evid
data
middl
east
respiratori
syndrom
coronaviru
merscov
sever
acut
respiratori
syndrom
sar
coronavirus
way
consid
indirect
evid
publish
data
support
care
icu
studi
influenza
respiratori
viral
infect
acut
respiratori
distress
syndrom
ard
sepsi
period
autom
electron
search
sent
assign
panel
member
everi
week
identifi
relev
new
evid
emerg
accordingli
issu
guidelin
releas
order
updat
recommend
need
formul
new
one
aerosolgener
procedur
icu
includ
endotrach
intub
bronchoscopi
open
suction
administr
nebul
treatment
manual
ventil
intub
physic
prone
patient
disconnect
patient
ventil
noninvas
posit
pressur
ventil
tracheostomi
cardiopulmonari
resuscit
similar
reason
factor
maxim
chanc
first
pass
success
use
intub
patient
suspect
confirm
thu
recommend
healthcar
oper
experi
skill
airway
manag
first
attempt
intub
diagnosi
base
rtpcr
test
respiratori
sampl
nasopharyng
oropharyng
swab
lower
respiratori
tract
sampl
whenev
possibl
bronchoalveolar
lavag
limit
perform
indic
adequ
precaut
due
risk
aerosol
consequ
exposur
healthcar
profession
similarli
sputum
induct
avoid
due
increas
risk
aerosol
tracheal
aspir
specimen
appear
carri
lower
risk
aerosol
sometim
obtain
without
disconnect
patient
ventil
procedur
involv
laboratori
rtpcr
test
use
number
assay
current
use
well
describ
despit
gener
high
sensit
specif
rtpcrbase
assay
may
enough
reli
oropharyng
swab
specimen
alon
diagnosi
due
low
neg
predict
valu
recent
studi
oropharyng
swab
patient
test
posit
rtpcr
similar
data
report
use
rtpcr
sar
epidem
use
seroconvers
gold
standard
sar
diagnosi
rtpcr
assay
perform
nasopharyng
throat
specimen
posit
time
respect
howev
fals
posit
observ
indic
assay
specif
similarli
studi
account
ct
scan
find
among
suspect
case
neg
oropharyng
nasal
swab
consid
highli
like
case
consid
probabl
case
consequ
singl
neg
swab
upper
airway
rule
infect
repeat
sampl
multipl
site
includ
lower
airway
increas
diagnost
yield
similarli
given
coinfect
viral
pathogen
observ
posit
test
anoth
respiratori
viru
rule
delay
test
high
suspicion
given
high
specif
singl
posit
swab
confirm
diagnosi
enough
trigger
infect
control
precaut
appropri
treatment
patient
lower
respiratori
tract
specimen
consid
give
higher
diagnost
yield
upper
respiratori
specimen
patient
pneumonia
consist
observ
sar
therefor
obtain
whenev
possibl
report
preval
shock
adult
patient
highli
variabl
depend
patient
popul
studi
sever
ill
definit
shock
recent
report
summar
epidemiolog
characterist
chines
patient
diagnos
critic
case
defin
sever
hypoxemia
andor
presenc
organ
failur
includ
shock
anoth
chines
studi
patient
similar
sever
ill
develop
shock
hospit
patient
incid
like
higher
tabl
may
reach
among
patient
icu
cardiac
injuri
elev
cardiac
injuri
biomark
percentil
upper
refer
limit
report
patient
wuhan
china
preval
cardiac
injuri
may
correl
preval
shock
lack
systemat
screen
cardiac
dysfunct
hemodynam
stabl
patient
mean
associ
taken
certain
tabl
prognosi
patient
shock
systemat
report
studi
patient
hospit
wuhan
china
shock
major
reason
death
may
least
part
due
fulmin
myocard
studi
risk
factor
associ
shock
patient
lack
major
avail
report
unadjust
estim
despit
methodolog
limit
studi
suggest
older
age
comorbid
especi
diabet
cardiovascular
diseas
includ
hypertens
lower
lymphocyt
count
higher
ddimer
level
possibl
cardiac
injuri
risk
factor
consid
sinc
direct
evid
patient
shock
panel
base
recommend
indirect
evid
critic
ill
patient
gener
systemat
review
metaanalysi
identifi
rct
n
compar
albumin
crystalloid
use
demonstr
signific
differ
allcaus
mortal
end
followup
rr
ci
within
day
rr
ci
within
rr
ci
risk
blood
transfus
rr
ci
rrt
rr
ci
also
similar
absenc
benefit
albumin
consid
cost
limit
avail
suggest
routin
use
initi
resuscit
patient
shock
remark
typic
corticosteroid
regimen
septic
shock
intraven
hydrocortison
mg
per
day
administ
either
infus
intermitt
dose
data
exist
use
steroid
patient
shock
panel
base
recommend
indirect
evid
critic
ill
patient
gener
systemat
review
rct
n
patient
compar
lowdos
corticosteroid
therapi
versu
corticosteroid
therapi
adult
patient
septic
shock
clinic
practic
guidelin
report
signific
differ
shortterm
mortal
rr
ci
longterm
mortal
rr
ci
seriou
advers
event
rr
ci
howev
time
resolut
shock
length
stay
icu
hospit
shorter
corticosteroid
therapi
time
resolut
shock
length
stay
especi
icu
import
cost
consider
suggest
use
lowdos
corticosteroid
therapi
patient
refractori
shock
provid
guidanc
patient
respiratori
failur
absenc
refractori
shock
adult
present
hypox
respiratori
failur
direct
evid
support
use
nippv
furthermor
prior
studi
suggest
may
associ
increas
risk
infect
transmiss
healthcar
worker
metaanalys
rct
show
reduct
intub
mortal
risk
nippv
hypox
respiratori
failur
howev
metaanalys
includ
studi
focus
immunocompromis
acut
cardiogen
pulmonari
edema
postop
patient
find
may
therefor
less
applic
patient
acut
hypoxem
respiratori
failur
ard
common
present
acut
hypoxem
respiratori
failur
etiolog
cardiogen
pulmonari
edema
nippv
high
failur
rate
one
rct
failur
report
patient
hypox
respiratori
failur
ventil
nippv
patient
therefor
requir
intub
addit
patient
hypox
respiratori
failur
random
nippv
higher
mortal
ci
treat
convent
oxygen
therapi
ci
hfnc
ci
p
cohort
middl
east
respiratori
syndrom
mer
patient
nippv
associ
improv
mortal
length
stay
compar
patient
intub
without
tri
nippv
howev
nippv
associ
high
failur
rate
lead
intub
patient
receiv
nippv
prior
intub
increas
inhal
nitric
oxid
requir
increas
mortal
failur
rate
pandem
influenza
sar
rang
demonstr
efficaci
mainli
come
case
seri
observ
studi
rather
rct
lead
practic
variat
china
use
nippv
pandem
respiratori
infect
common
wherea
guidelin
europ
hong
kong
us
advis
nippv
firstlin
therapi
addit
concern
use
nippv
respiratori
pandem
like
nippv
may
aggrav
sever
form
lung
injuri
result
injuri
transpulmonari
pressur
larg
tidal
volum
may
delay
initi
invas
mechan
ventil
lead
emerg
unstabl
intub
increas
risk
transmiss
healthcar
team
addit
nippv
aerosolgener
procedur
increas
risk
transmiss
diseas
healthcar
worker
sever
studi
metaanalys
sar
also
highlight
risk
nosocomi
spread
diseas
nippv
balanc
benefit
harm
use
nippv
adult
unclear
certain
patient
form
respiratori
failur
acut
hypercapn
respiratori
failur
acut
cardiogen
pulmonari
edema
known
caus
respiratori
failur
nippv
may
benefici
howev
limit
experi
nippv
pandem
suggest
high
failur
rate
recommend
patient
receiv
nippv
monitor
close
care
set
intub
facilit
event
decompens
howev
resourc
becom
stretch
may
insuffici
abil
provid
invas
ventil
even
moder
chanc
success
nippv
may
justifi
use
nippv
use
helmet
nippv
attract
option
avail
singlecent
rct
show
decreas
intub
improv
mortal
nippv
deliv
helmet
ard
patient
particular
import
set
pandem
nippv
helmet
also
shown
reduc
exhal
air
dispers
wherea
face
mask
insuffici
howev
helmet
nippv
expens
without
direct
evid
benefit
patient
resourc
util
acquir
equip
alreadi
avail
figur
summar
recommend
hfnc
nippv
patient
current
studi
address
mechan
ventil
strategi
patient
howev
panel
expert
believ
mechan
ventil
patient
manag
similarli
patient
acut
respiratori
failur
icu
mechan
ventil
potenti
lifesav
intervent
worsen
lung
injuri
ventilatorinduc
lung
injuri
vili
contribut
multiorgan
failur
patient
ard
one
main
ventil
strategi
minim
vili
low
vt
ventil
systemat
review
metaanalysi
rct
found
invers
associ
larger
vt
gradient
mortal
addit
author
found
use
protocol
low
vt
strategi
high
peep
rct
patient
reduc
risk
death
rr
ci
analysi
rct
patient
show
reduct
hospit
mortal
low
vt
ventil
rr
ci
basi
avail
bodi
evid
sever
guidelin
recommend
use
low
vt
mlkg
predict
bodi
weight
patient
ard
panel
judg
magnitud
benefit
moder
cost
low
intervent
accept
feasibl
implement
therefor
issu
strong
recommend
use
low
vt
mlkg
predict
bodi
weight
ventil
patient
ard
fig
clinic
trial
examin
effect
plateau
pressur
pplat
limit
induc
ard
howev
larg
bodi
indirect
evid
patient
ard
along
low
vt
ventil
pplat
limit
lung
protect
strategi
limit
vili
systemat
review
metaanalysi
rct
found
use
lung
protect
strategi
includ
protocol
low
vt
pplat
cm
rct
patient
reduc
risk
death
rr
ci
subsequ
metaanalysi
rct
compar
ventilatori
strategi
low
high
pplat
patient
ard
studi
found
shortterm
mortal
higher
patient
pplat
cm
first
week
icu
day
rr
ci
day
rr
ci
day
rr
ci
basi
avail
bodi
evid
sever
guidelin
recommend
keep
pplat
cm
patient
ard
panel
judg
magnitud
benefit
moder
cost
low
patient
valu
consist
intervent
accept
feasibl
implement
therefor
issu
strong
recommend
keep
pplat
cm
ventil
patient
ard
remark
use
higher
peep
strategi
ie
peep
cm
clinician
monitor
patient
barotrauma
ard
extrins
peep
use
prevent
repeat
open
close
alveoli
ie
atelectotrauma
therefor
reduc
vili
addit
peep
increas
sustain
alveolar
recruit
improv
oxygen
reduc
oxygen
requir
clinic
trial
examin
effect
peep
coronavirusinduc
ard
howev
larg
bodi
indirect
evid
patient
ard
individu
patient
data
metaanalysi
ipdma
three
largest
trial
patient
high
peep
found
differ
inhospit
mortal
patient
rr
ci
howev
patient
ard
higher
peep
strategi
result
lower
icu
mortal
rr
ci
lower
inhospit
mortal
rr
ci
reduct
use
rescu
therapi
rr
ci
expens
possibl
increas
risk
pneumothorax
recent
systemat
review
metaanalysi
nine
rct
patient
examin
effect
higher
peep
strategi
patientimport
outcom
overal
higher
peep
strategi
reduc
hospit
mortal
rr
ci
howev
subgroup
trial
enrol
patient
oxygen
respons
peep
rct
patient
use
high
peep
significantli
reduc
inhospit
mortal
compar
lower
peep
strategi
rr
ci
although
bodi
evid
suggest
benefici
effect
higher
peep
select
patient
result
like
confound
fact
low
vt
ventil
use
control
arm
trial
clear
agre
upon
definit
higher
peep
moreov
optim
peep
level
ard
patient
unknown
like
vari
base
extent
diseas
lung
complianc
factor
aforement
ipdma
median
peep
level
high
peep
arm
cm
day
respect
compar
median
valu
cm
day
low
peep
arm
although
arbitrari
clinician
could
consid
peep
level
cm
constitut
higher
peep
strategi
peep
level
cm
lower
peep
strategi
seri
patient
radiograph
featur
progress
first
week
symptom
onset
predomin
ground
glass
opac
mix
pattern
predomin
basilar
consolid
latter
pattern
may
suggest
role
prone
ventil
prone
posit
theoret
make
ventil
homogen
decreas
ventral
alveolar
distent
dorsal
alveolar
collaps
may
reduc
differ
dorsal
ventral
transpulmonari
pressur
addit
reduc
lung
compress
improv
perfus
recent
studi
describ
clinic
cours
icu
show
prone
ventil
use
patient
howev
studi
avail
describ
clinic
cours
patient
ventil
prone
posit
recent
systemat
review
metaanalysi
nine
rct
patient
show
prone
ventil
least
hour
patient
moder
sever
ard
reduc
mortal
rct
rr
ci
effect
mortal
studi
use
prone
ventil
hour
rct
rr
ci
hand
prone
ventil
increas
risk
pressur
sore
rr
ci
endotrach
tube
obstruct
rr
ci
systemat
review
reach
similar
conclus
moder
certainti
prone
ventil
hour
patient
moder
sever
ard
reduc
mortal
may
increas
risk
pressur
sore
endotrach
tube
obstruct
healthcar
worker
prone
patient
train
proper
techniqu
prone
take
infect
control
precaut
event
accident
endotrach
tube
disconnect
ventil
prone
associ
signific
cost
believ
may
provid
signific
benefit
prone
implement
low
middleincom
set
effort
made
provid
necessari
train
educ
healthcar
worker
facilit
practic
http
wwwyoutubecomwatch
remark
due
resourceintens
natur
ecmo
need
experienc
center
healthcar
worker
infrastructur
ecmo
consid
care
select
patient
sever
ard
clinic
trial
ecmo
patient
recent
report
china
suggest
case
icu
receiv
ecmo
clinic
cours
outcom
patient
report
yet
ministri
health
saudi
arabia
establish
ecmo
program
merscov
epidem
retrospect
cohort
studi
patient
merscov
refractori
hypoxemia
group
patient
receiv
vv
ecmo
lower
inhospit
mortal
vs
p
howev
cohort
studi
high
risk
select
bia
given
retrospect
design
two
rct
evalu
ecmo
vs
convent
mechan
ventil
sever
ard
guidelin
publish
unabl
provid
specif
guidanc
use
ecmo
research
recommend
although
recent
rct
eolia
stop
earli
futil
reanalysi
trial
use
bayesian
approach
provid
favor
interpret
suggest
lower
mortal
ecmo
sever
ard
recent
systemat
review
includ
two
rct
patient
found
reduct
mortal
ecmo
rr
ci
risk
major
bleed
higher
ecmo
ecmo
resourceintens
techniqu
restrict
special
center
remain
extrem
limit
resourc
therefor
use
rescu
therapi
reserv
care
select
patient
futur
studi
describ
outcom
patient
ecmo
mechan
death
advanc
understand
guid
practic
remark
major
panel
support
weak
recommend
ie
suggest
use
steroid
sickest
patient
ard
howev
lowqual
evid
expert
panel
prefer
issu
recommend
higher
qualiti
direct
evid
avail
remark
treat
team
initi
empir
antimicrobi
assess
deescal
daili
reevalu
durat
therapi
spectrum
coverag
base
microbiolog
result
patient
clinic
statu
tocilizumab
human
immunoglobulin
function
immun
respons
block
interleukin
il
receptor
bind
approv
cr
inflammatori
condit
relat
relat
inflamm
rheumatoid
arthriti
juvenil
idiopath
arthriti
sever
ill
patient
may
extrem
immun
respons
lead
sever
respiratori
failur
case
inhibit
may
help
attenu
cytokin
releas
syndrom
reduc
cytokin
concentr
acut
phase
reactant
product
ongo
trial
tocilizumab
help
address
safeti
efficaci
therapi
rheumatoid
arthriti
literatur
systemat
review
metaanalysi
six
rct
dose
mgkg
dose
show
increas
risk
advers
event
compar
control
treatment
ci
increas
risk
infect
ci
anoth
systemat
review
metaanalysi
rct
tocilizumab
rheumatoid
arthriti
found
increas
risk
infecti
respiratori
advers
event
rr
ci
data
safeti
efficaci
tocilizumab
unabl
issu
recommend
nafamostat
synthet
serin
proteas
inhibitor
potent
inhibitor
mer
cov
nitazoxanid
antiprotozo
agent
antivir
potenti
sever
respiratori
virus
includ
influenza
parainfluenza
respiratori
syncyti
viru
rhinoviru
vitro
studi
show
nafamostat
nitazoxanid
inhibit
rct
patient
acut
uncompl
influenza
demonstr
use
nitazoxanid
reduc
durat
symptom
howev
hospit
patient
sever
acut
respiratori
infect
mexico
nitazoxanid
found
superior
placebo
would
like
acknowledg
dr
zainab
al
duhailib
kimberli
lewi
malik
farooqi
jessica
bartoszko
support
conduct
systemat
review
metaanalys
guidelin
question
